Literature DB >> 18524989

SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment.

Bo Huang1, Zhang Lei, Gui-Mei Zhang, Dong Li, Chuanwang Song, Bo Li, Yanyan Liu, Ye Yuan, Jay Unkeless, Huabao Xiong, Zuo-Hua Feng.   

Abstract

Despite the evidence for the role of inflammation in cancer initiation, promotion, and progression, the precise mechanism by which the inflammation within tumor is orchestrated by inflammatory cells remains to be determined. Here, we report that tumor-infiltrating mast cells remodel tumor microenvironment and promote tumor growth. Mast cell infiltration and activation in tumors were mainly mediated by tumor-derived stem cell factor (SCF) and its receptor c-Kit on mast cells. Low concentrations of SCF efficiently induced the chemotactic migration of mast cells. Tumor-infiltrating mast cells, activated by higher concentrations of SCF, expressed multiple proinflammatory factors and increased IL-17 expression in tumors. The activity of NF-kappaB and AP-1 in tumor cells was intensified in the mast cell-remodeled inflammatory microenvironment. SCF-activated mast cells also exacerbated tumor immunosuppression by releasing adenosine and increasing T regulatory cells, which augmented the suppression of T cells and natural killer cells in tumors. These findings emphasize that the remodeling of the tumor microenvironment can actually be initiated by tumor cell-released SCF and suggest that mast cells are not only a participator but also a critical regulator of inflammation and immunosuppression in the tumor microenvironment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18524989      PMCID: PMC2515142          DOI: 10.1182/blood-2008-03-147033

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  54 in total

Review 1.  Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer.

Authors:  Michael Karin; Toby Lawrence; Victor Nizet
Journal:  Cell       Date:  2006-02-24       Impact factor: 41.582

Review 2.  KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  Appl Immunohistochem Mol Morphol       Date:  2005-09

3.  Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: role in cell migration.

Authors:  Nick Di Girolamo; Ikuko Indoh; Nicole Jackson; Denis Wakefield; H Patrick McNeil; Weixing Yan; Carolyn Geczy; Jonathan P Arm; Nicodemus Tedla
Journal:  J Immunol       Date:  2006-08-15       Impact factor: 5.422

4.  Toll-like receptors on tumor cells facilitate evasion of immune surveillance.

Authors:  Bo Huang; Jie Zhao; Hongxing Li; Kai-Li He; Yibang Chen; Shu-Hsia Chen; Lloyd Mayer; Jay C Unkeless; Huabao Xiong
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

Review 5.  Development, migration, and survival of mast cells.

Authors:  Yoshimichi Okayama; Toshiaki Kawakami
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

6.  Mast cells are essential intermediaries in regulatory T-cell tolerance.

Authors:  Li-Fan Lu; Evan F Lind; David C Gondek; Kathy A Bennett; Michael W Gleeson; Karina Pino-Lagos; Zachary A Scott; Anthony J Coyle; Jennifer L Reed; Jacques Van Snick; Terry B Strom; Xin Xiao Zheng; Randolph J Noelle
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

7.  Fyn kinase acts upstream of Shp2 and p38 mitogen-activated protein kinase to promote chemotaxis of mast cells towards stem cell factor.

Authors:  Lionel A Samayawardhena; Jinghui Hu; Paul L Stein; Andrew W B Craig
Journal:  Cell Signal       Date:  2006-01-25       Impact factor: 4.315

8.  Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo.

Authors:  Andreas A Erdmann; Zhan-Guo Gao; Unsu Jung; Jason Foley; Todd Borenstein; Kenneth A Jacobson; Daniel H Fowler
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

9.  RabGEF1 regulates stem cell factor/c-Kit-mediated signaling events and biological responses in mast cells.

Authors:  Janet Kalesnikoff; Eon J Rios; Ching-Cheng Chen; Susumu Nakae; Brian A Zabel; Eugene C Butcher; Mindy Tsai; See-Ying Tam; Stephen J Galli
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

10.  The inflammatory cytokine tumor necrosis factor-alpha generates an autocrine tumor-promoting network in epithelial ovarian cancer cells.

Authors:  Hagen Kulbe; Richard Thompson; Julia L Wilson; Stephen Robinson; Thorsten Hagemann; Rewas Fatah; David Gould; Ayse Ayhan; Frances Balkwill
Journal:  Cancer Res       Date:  2007-01-15       Impact factor: 12.701

View more
  101 in total

1.  Crosstalk between mast cells and pancreatic cancer cells contributes to pancreatic tumor progression.

Authors:  Matthew J Strouch; Eric C Cheon; Mohammad R Salabat; Seth B Krantz; Elias Gounaris; Laleh G Melstrom; Surabhi Dangi-Garimella; Edward Wang; Hidayatullah G Munshi; Khashayarsha Khazaie; David J Bentrem
Journal:  Clin Cancer Res       Date:  2010-04-06       Impact factor: 12.531

2.  FcepsilonRI-mediated mast cell migration: signaling pathways and dependence on cytosolic free Ca2+ concentration.

Authors:  In Duk Jung; Hyun-Sil Lee; Hoi Young Lee; Oksoon Hong Choi
Journal:  Cell Signal       Date:  2009-07-24       Impact factor: 4.315

Review 3.  Mast cell plasticity and sphingosine-1-phosphate in immunity, inflammation and cancer.

Authors:  Carole A Oskeritzian
Journal:  Mol Immunol       Date:  2014-04-22       Impact factor: 4.407

4.  ADAM10 is required for SCF-induced mast cell migration.

Authors:  Travis W Faber; Nicholas A Pullen; Josephine F A Fernando; Elizabeth Motunrayo Kolawole; Jamie J A McLeod; Marcela Taruselli; Kathryn L Williams; Kevin O Rivera; Brian O Barnstein; Daniel H Conrad; John J Ryan
Journal:  Cell Immunol       Date:  2014-05-21       Impact factor: 4.868

Review 5.  Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation.

Authors:  Steven Maltby; Khashayarsha Khazaie; Kelly M McNagny
Journal:  Biochim Biophys Acta       Date:  2009-02-21

Review 6.  Mast cells as regulators of adaptive immunity to tumours.

Authors:  A Wasiuk; V C de Vries; K Hartmann; A Roers; R J Noelle
Journal:  Clin Exp Immunol       Date:  2008-12-05       Impact factor: 4.330

Review 7.  Mast cell and T cell communication; amplification and control of adaptive immunity.

Authors:  Alon Y Hershko; Juan Rivera
Journal:  Immunol Lett       Date:  2009-11-10       Impact factor: 3.685

8.  PGD2 deficiency exacerbates food antigen-induced mast cell hyperplasia.

Authors:  Tatsuro Nakamura; Shingo Maeda; Kazuhide Horiguchi; Toko Maehara; Kosuke Aritake; Byung-Il Choi; Yoichiro Iwakura; Yoshihiro Urade; Takahisa Murata
Journal:  Nat Commun       Date:  2015-07-10       Impact factor: 14.919

9.  Mast cells mobilize myeloid-derived suppressor cells and Treg cells in tumor microenvironment via IL-17 pathway in murine hepatocarcinoma model.

Authors:  Zhuoshun Yang; Biao Zhang; Dapeng Li; Meng Lv; Chunmei Huang; Guan-Xin Shen; Bo Huang
Journal:  PLoS One       Date:  2010-01-27       Impact factor: 3.240

10.  Regulation of HIF-1alpha and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration.

Authors:  Zhang Lei; Bo Li; Zhuoshun Yang; Haoshu Fang; Gui-Mei Zhang; Zuo-Hua Feng; Bo Huang
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.